Reiner Leidl : Citation Profile


Are you Reiner Leidl?

Ludwig-Maximilians-Universität München (50% share)
Helmholtz Zentrum für Gesundheit und Umwelt (50% share)

5

H index

1

i10 index

88

Citations

RESEARCH PRODUCTION:

39

Articles

3

Papers

RESEARCH ACTIVITY:

   37 years (1983 - 2020). See details.
   Cites by year: 2
   Journals where Reiner Leidl has often published
   Relations with other researchers
   Recent citing documents: 2.    Total self citations: 9 (9.28 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/ple1128
   Updated: 2024-01-16    RAS profile: 2022-10-14    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Holle, Rolf (2)

Wichert, Sebastian (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Reiner Leidl.

Is cited by:

Blankart, Katharina (5)

Thomsen, Stephan (3)

Arntz, Melanie (3)

Nuscheler, Robert (2)

Holle, Rolf (2)

Jones, Andrew (2)

Mortimer, Duncan (2)

Morris, Stephen (2)

Black, Nicole (2)

Gu, Yuanyuan (1)

Patxot, Concepció (1)

Cites to:

Leidl, Reiner (9)

Devlin, Nancy (8)

Johannesson, Magnus (7)

Blankart, Katharina (7)

Spiess, Katharina (6)

Parkin, David (6)

Cawley, John (6)

Husereau, Don (5)

Mullahy, John (5)

Schreyögg, Jonas (4)

Viscusi, W (4)

Main data


Where Reiner Leidl has published?


Journals with more than one article published# docs
Health Policy8
PharmacoEconomics6
The European Journal of Health Economics4
Health Economics4
PLOS ONE3
DIW Wochenbericht2
IJERPH2
Economics & Human Biology2

Working Papers Series with more than one paper published# docs
Munich Reprints in Economics / University of Munich, Department of Economics2

Recent works citing Reiner Leidl (2024 and 2023)


YearTitle of citing document
2023Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial. (2023). Fransson, Per ; Beckman, Lars ; Anden, Mats ; Salen, Klas-Goran ; Jonsson, Hkan ; Sun, Sun. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01467-5.

Full description at Econpapers || Download paper

2023Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries. (2023). Mossakowska, Magorzata ; Avedano, Luisa ; Sajak-Szczerba, Magdalena ; Kawalec, Pawe ; Holko, Przemysaw. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01536-9.

Full description at Econpapers || Download paper

Works by Reiner Leidl:


YearTitleTypeCited
2000Auswirkungen der demographischen Alterung auf den Versorgungsbedarf im Krankenhausbereich: Modellrechnungen bis zum Jahre 2050 In: DIW Wochenbericht.
[Citation analysis]
article0
2001Starker Anstieg der Pflegebedürftigkeit zu erwarten: Vorausschätzungen bis 2020 mit Ausblick auf 2050 In: DIW Wochenbericht.
[Citation analysis]
article1
2001Auswirkungen der demographischen Entwicklung auf die Zahl der Pflegefälle: Vorausschätzungen bis 2020 mit Ausblick auf 2050 In: Discussion Papers of DIW Berlin.
[Full Text][Citation analysis]
paper0
2014Development of BMI values of German children and their healthcare costs In: Economics & Human Biology.
[Full Text][Citation analysis]
article5
2011Relative weight-related costs of healthcare use by children--Results from the two German birth cohorts, GINI-plus and LISA-plus In: Economics & Human Biology.
[Full Text][Citation analysis]
article6
2011A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention In: Health Policy.
[Full Text][Citation analysis]
article4
2013Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis In: Health Policy.
[Full Text][Citation analysis]
article4
1995AIDS scenarios for The Netherlands; the economic impact on hospitals In: Health Policy.
[Full Text][Citation analysis]
article1
1996Making cost assessments based on RCTs more useful to decision-makers In: Health Policy.
[Full Text][Citation analysis]
article3
1997Hospital care for persons with AIDS in the European Union In: Health Policy.
[Full Text][Citation analysis]
article2
1998Disease-staging for modelling current and future health-care impact of disease: illustrations for Diabetes Mellitus and AIDS In: Health Policy.
[Full Text][Citation analysis]
article0
2004The impact of ageing on hospital care and long-term care--the example of Germany In: Health Policy.
[Full Text][Citation analysis]
article19
1988Training health services managers: improving health by more health economics? In: Health Policy.
[Full Text][Citation analysis]
article0
In: .
[Full Text][Citation analysis]
article1
In: .
[Full Text][Citation analysis]
article4
1983Einzelbesprechungen In: Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik).
[Full Text][Citation analysis]
article0
2000Hospital care for p ersons with AIDS in European?Union countries; a cross?country comparison In: Health Care Management Science.
[Full Text][Citation analysis]
article0
2008A model to decompose the performance of supplementary private health insurance markets In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]
article0
2019Patient characteristics and valuation changes impact quality of life and satisfaction in total knee arthroplasty results from a German prospective cohort study In: Munich Reprints in Economics.
[Citation analysis]
paper0
2019Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study In: Munich Reprints in Economics.
[Citation analysis]
paper2
2019Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study.(2019) In: Health Economics Review.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2
article
2003Medical Progress and Supplementary Private Health Insurance In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article0
2014The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data In: PLOS ONE.
[Full Text][Citation analysis]
article1
2015Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review In: PLOS ONE.
[Full Text][Citation analysis]
article0
2015Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review In: PLOS ONE.
[Full Text][Citation analysis]
article0
2004A Comparison of Different Strategies to Collect Standard Gamble Utilities In: Medical Decision Making.
[Full Text][Citation analysis]
article0
2014Analysing coverage decision-making: opening Pandora’s box? In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2015Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2020Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, h In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2002Overview of economic evaluation of positron-emission tomography In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2007Advertising bans as a means of tobacco control policy: a systematic literature review of time-series analyses In: International Journal of Public Health.
[Full Text][Citation analysis]
article2
2006Costs of Inflammatory Bowel Disease in Germany In: PharmacoEconomics.
[Full Text][Citation analysis]
article7
2008Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2012A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease In: PharmacoEconomics.
[Full Text][Citation analysis]
article5
2014A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2015Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2020Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2004A utility?theoretic approach to the aggregation of willingness to pay measured in decomposed scenarios: development and empirical test In: Health Economics.
[Full Text][Citation analysis]
article2
2006A preference?based index for the SF?12 In: Health Economics.
[Full Text][Citation analysis]
article3
1996The impact of age on cost?effectiveness ratios and its control in decision making In: Health Economics.
[Full Text][Citation analysis]
article3
1998Health economic assessment of behavioural rehabilitation in chronic low back pain: a randomised clinical trial In: Health Economics.
[Full Text][Citation analysis]
article1
2006Gesundheitspolitik in der Kompromissfalle: Kein Problem gelöst, aber neue geschaffen In: Wirtschaftsdienst – Zeitschrift für Wirtschaftspolitik (1949 - 2007).
[Full Text][Citation analysis]
article1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 10 2023. Contact: CitEc Team